InvestorsHub on MSN
Emergent BioSolutions gets FDA clearance for new OTC NARCAN nasal spray portable case
Emergent BioSolutions (NYSE:EBS) said the U.S. Food and Drug Administration has approved a supplemental New Drug Application ...
Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.
Wellness at Penn and Penn MERT hosted a Narcan administration training and resources table on Locust Walk on March 12. At the training table, Wellness at Penn and MERT officers offered brief Narcan ...
Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid ...
Bystanders in Steuben County administered Narcan at least 16 times in 2025, potentially saving 16 lives. Future goals include training more local businesses and expanding the installation of Emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results